Inventor
Haiqun Tang
Inventor
Belle Mead, NJ, US
Overview
Patents· 16 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds29%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
A61KPreparations for medical, dental or toiletry purposes19%
C07CAcyclic or carbocyclic compounds10%
Y02ATechnologies for adaptation to climate change8%
B01JChemical or physical processes, e.g. catalysis or colloid chemistry4%
Y02PClimate change mitigation technologies in the production or processing of goods4%
PatentTitleYear
11,084,765Device and method for preparing para-xylene and co-producing light olefins from methanol and/or dimethyl ether and benzene202111,072,571Fluidized bed reactor and method for producing para-xylene and co-producing light olefins from benzene and methanol and/or dimethyl ether202110,544,130Metallo-beta-lactamase inhibitors202010,414,774Compound useful for altering the levels of bile acids for the treatment of diabetes and cardiometabolc disease201910,414,775Compounds useful for altering the levels of bile acids for the treatment of diabetes and cardiometabolic disease201910,227,331Metallo-b-lactamase inhibitors201910,221,163Metallo-beta-lactamase inhibitors20199,839,642'Beta-tetrazolyl-propionic acids as metallo-beta-lactamase inhibitors'20179,708,336'Metallo-beta-lactamase inhibitors'20179,586,948'Inhibitors of IRAK4 activity'20178,927,559'Quinazolinone-type compounds as CRTH2 antagonists'20158,569,521'Benzenesulfonyl-chromane, thiochromane, tetrahydronaphthalene and related gamma secretase inhibitors'20138,067,621'Benzenesulfonyl-chromane, thiochromane, tetrahydronaphthalene and related gamma secretase inhibitors'20117,723,342'Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia'20107,361,769'Heterocyclyls as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders'20087,348,328'MCH antagonists for the treatment of obesity'2008Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2008–2011Patents assigned to SCHERING CORP (4)· patent assignee history
2008–2019Based in Belle Mead, NJ, US· patent location history
2011–2019Patents assigned to TANG HAIQUN (4)· patent assignee history
2011–2013Patents assigned to ASBEROM THEODROS (2)· patent assignee history
2011–2013Patents assigned to BARA THOMAS A (2)· patent assignee history
2013–2020Patents assigned to MERCK SHARP & DOHME (10)· patent assignee history
2020Based in Belle Meade, NJ, US· patent location history
2021Based in Dalian, CN· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| MERCK SHARP & DOHME | 10 | 2013–2020 |
| SCHERING CORP | 4 | 2008–2011 |
| TANG HAIQUNself | 4 | 2011–2019 |
| ASBEROM THEODROS | 2 | 2011–2013 |
| BARA THOMAS A | 2 | 2011–2013 |
Locations
| Location | Patents | Span |
|---|---|---|
| Belle Mead, New Jersey, US | 13 | 2008–2019 |
| Dalian, CN | 2 | 2021 |
| Belle Meade, New Jersey, US | 1 | 2020 |